Keratinocyte growth factor (KGF; palifermin or repifermin), intravenous vs placebo
Number of days unable to take medicine orally · Adults with cancer receiving treatment
The review found no eligible studies for this question.
1 finding from 1 review
- Interventions for preventing oral mucositis in patients with cancer receiving treatment: cytokines and growth factors 2017 · Cochrane All outcomesNo studies reported this outcome (planned secondary outcome not measured by any study in the review)0 studiesNo studies found